Magazine Article | July 1, 2020

5 Bad Habits The Clinical Trial Community Needs To Break ASAP

Source: Life Science Leader

By Dean Gittleman

The issue of clinical trial costs, both in terms of money and time, is big, complicated, and not at all new. In this article, I will not attempt to address or solve all of the problems that contribute to these high costs, but I will highlight some continuing root causes that I believe persist needlessly.

I’ll focus on execution, leaving issues surrounding study design complexity and lack of discipline to another day. Tradition and inertia are poor excuses to continue perpetuating some of these practices — conducting 21st-century trials with a 20th-century mindset is bound to fail.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: